Pharmacokinetics of liposomes designed to carry glucocorticoids

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 1063-1070

  Hrynyk, Rafal ^a   Storm, Gert ^c   Metselaar, Bart ^c   Langner, Marek ^a,b  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b Academic Centre for the Biotechnology of Lipid Aggregates   (Poland)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Glucocorticoid; Liposome; Pharmacokinetics; Uptake

Indexed keywords

GLUCOCORTICOID; LIPOSOME; MACROGOL 2000; OPSONIN; PREDNISOLONE 21 PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG RELEASE; DRUG TISSUE LEVEL; DRUG UPTAKE; MACROPHAGE; MALE; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; SPLEEN; THEORETICAL MODEL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANIMALS; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; INJECTIONS, INTRAVENOUS; LIPOSOMES; LIVER; MALE; MODELS, BIOLOGICAL; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; SPLEEN; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 1642421118     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Harashima H., Sakata K., Kiwada H.: Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes. Pharmacol. Res., 1993, 10, 606-610.
2. Harashima H., Yamane C., Kume Y., Kiwada H.: Kinetic Analysis of A UC-dependent saturable clearance of liposomes: mathematical description of AUC dependency. J. Pharmacokin. Biopharm., 1993, 21, 299-308.
3. Harrington K.J., Lewanski C.R., Stewart J.S.W.: Liposomes as vehicles for targeted therapy of cancer. Part 1: Preclinical development. Clin. Oncol., 2000, 12, 2-15.
4. Harrington K.J., Lewanski C.R., Stewart J.S.W.: Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development. Clin. Oncol., 2000, 12, 16-24.
5. Harrington K.J., Rowlinson-Busza G., Syrigos K.N., Uster P.S., Vile R.G., Stewart J.S.W.: Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery. Clin. Cancer Res., 2000, 6, 2528-2537.
6. Jain R.K.: Delivery of molecular and cellular medicine to solid tumors. Advan. Drug Delivery Rev., 2001, 46, 149-168.
7. Langner M.: Effect of liposome molecular composition on its ability to carry drugs. Pol. J. Pharmacol., 2000, 52, 3-14.
8. Langner M., Kral T.: Liposome-based drug delivery systems. Pol. J. Pharmacol., 1999, 51, 211-222.
9. Lasic D.D., Needham D.: The "stealth" liposome: a prototypical biomaterial. Chem. Rev., 1995, 95, 2601-2634.
10. Leverman P., Boerman O.C., Oyen W.J., Dams E.T., Storm G., Corstens F.H.: Liposomes for scintographic detection of infection and inflammation. Advan. Drug Delivery Rev., 1999, 37, 225-235.
11. Laverman P., Brouwers A.H., Dams E.T.M., Oyen W.J.G., Storm G., van Rooijen N., Corstens F.H.M., Boerman O.C.: Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J. Pharmacol. Exp. Ther., 2000, 293, 996-1001.
12. Laverman P., Carstens M.G., Boerman O.C., Dams E.Th.M., Oyen W.J.G., van Rooijen N., Corstens F.H.M., Storm G.: Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J. Pharmacol. Exp. Ther., 2001, 298, 607-612.
13. Lian T., Ho R.J.Y.: Trends and developments in liposome drug delivery systems. J. Pharm. Sci., 2001, 90, 667-680.
14. Maruyama K.: In vivo targeting by liposomes. Biol. Pharm. Bull., 2000, 23, 791-799.
15. Oussoren C., Storm G.: Role of macrophages in the localisation of liposomes in lymph nodes after subcutaneous administration. Int. J. Pharm., 1999, 183, 37-41.
16. Press W.H., Flannery B.P., Teukolsky S.A., Vetterling W.T.: Numerical Recipes in C: The Art of Scientific Computing. Cambridge University Press, 1993.
17. Scherphof G., Velinova M., Kamps J., Donga J., van der Want J.J.L., Kuipers F., Havekes L., Daemen T.: Modulation of pharmacokinetic behavior of liposomes. Advan. Drug Delivery Rev., 1997, 24, 179-191.
18. Storm G., Bakker-Woudenberg I.A.J.M., Schiffelers R.M., Oyen W.J.G., Crommelin D.J.A., Corstens F.H.M., Boerman O.C.: Diagnostic and therapeutic targeting of infectious and inflammatory diseases using sterically stabilized liposomes. In: Targeting of Drugs 6: Strategies for Stealth Therapeutic System. Eds. Gregoriadis G., McCormack M., Plenum Press, New York, 1998, 121-130.
19. Storm G., Crommelin D.J.A.: Liposomes: quo vadis? Pharm. Sci. Technol. Today, 1998, 1, 19-31.
20. Takeuchi H., Kojima H., Yamamoto H., Kawashima Y.: Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. J. Control. Release, 2001, 75, 83-91.